Tickerplace logo

Tickerplace

Cullinan Therapeutics, Inc. logo

CGEMCullinan Therapeutics, Inc.

CGEM Stock Price, Valuation & Chart | Cullinan Therapeutics, Inc.

Compare
$12.930-1.07 (-7.64%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Medical - Pharmaceuticals
OverviewFinancialsDividendsRatios

CGEM Historical price chart

CGEM Key Stats

Market Capitalization794.65M
PE Ratio-4.17
EPS-3.1
Trading Volume1.12M
Today's High/Low13.79/12.81
Dividend Yield0.00
52 Week High/Low23.19/6.73
Shares Outstanding61.46M
CGEM Financial Statement
CGEM Analyst ratings
CGEM Analysis & performance metrics

CGEM Company profile

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes…

CGEM Management team

Management
Nadim AhmedCEO
President, Chief Executive Officer & Director
Jeffrey Jones M.B.A., M.D., M.P.H.
Chief Medical Officer
Kevin A. Johnston
Chief Technical Operations Officer
Steve Andre
Chief Human Resources Officer
Rose Weldon
Senior Vice President of Corporate Affairs
Patrick A. Baeuerle Ph.D.
Co-Founder, Chief Scientific Advisor & Chairman of Scientific Advisory Board
Jacquelyn L. Sumer J.D.
Chief Legal Officer, Chief Compliance Officer & Corporate Secretary
Corinne Savill Ph.D.
Chief Business Officer
Total 8 executives

CGEM Frequently asked questions

What is Cullinan Therapeutics, Inc. (CGEM) Stock Price?

Current stock price of Cullinan Therapeutics, Inc. (CGEM) stock is $12.930. The stock price is -7.64% lower in the session. The intraday range can be seen from this page. Volume of Cullinan Therapeutics, Inc. (CGEM) stock is 1.12M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Cullinan Therapeutics, Inc. (CGEM) stock price going up or down today?

The stock price of Cullinan Therapeutics, Inc. (CGEM) can change with earnings, company news, and overall market sentiment. Cullinan Therapeutics, Inc. operates in the Healthcare / Medical - Pharmaceuticals market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Cullinan Therapeutics, Inc. stock expensive at its current price?

Whether Cullinan Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CGEM on this page is -4.17. EPS on this page is -3.10. Compare those figures with peers and growth expectations before deciding if the current Cullinan Therapeutics, Inc. price is justified.

How has the stock price of Cullinan Therapeutics, Inc. (CGEM) performed historically?

Historical performance for Cullinan Therapeutics, Inc. (CGEM) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CGEM reacted to past earnings and market events.

Should I buy Cullinan Therapeutics, Inc. (CGEM) stock, at this price?

Buying Cullinan Therapeutics, Inc. (CGEM) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.